Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue $ 4,696 $ 0
Operating expenses:    
Cost of revenues 16,792 0
Selling, general and administrative expenses 1,263,104 890,192
Research and development expenses 234,618 343,590
Total costs and expenses 1,514,514 1,233,782
Loss from operations (1,509,818) (1,233,782)
Other (expense) income:    
Interest expense (40,329) (29,266)
Decrease to fair value of derivative 0 108,944
Total other (expense) income (40,329) 79,678
Net loss $ (1,550,147) $ (1,154,104)
Loss per share - basic and diluted    
Net loss per common share - basic and diluted (in dollars per share) $ (0.01) $ (0.01)
Weighted common shares - basic and diluted (in shares) 236,789,063 193,044,766